Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-05-01

Clinical Trial Update: JeffQuit Group Therapy Program for Smoking Cessation in Patients With a History of Cancer [NA]

View source ↗

Summary

A clinical trial studying JeffQuit group therapy for smoking cessation in patients with a history of cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Current Smoker, Malignant Neoplasm | NA | Status: WITHDRAWN